Inhibition of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Mycobacterium tuberculosis: in silico screening and in vitro validation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European journal of medicinal chemistry

• Publication date

  2015-11-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejmech.2015.10.014PMID 26491981
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genomic insights into tuberculosis

  2014cited by this paper
• Synthesis and evaluation of dual site inhibitors of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase.

  2011cited by this paper
• Potent Inhibitors of a Shikimate Pathway Enzyme from Mycobacterium tuberculosis

  2011cited by this paper
• Drug-resistant tuberculosis: emerging treatment options

  2011cited by this paper
• In silico prediction of drug properties.

  2009cited by this paper
• Induced-fit docking studies of the active and inactive states of protein tyrosine kinases.

  2009cited by this paper
• Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

  2006cited by this paper
• VITAMIN E-SELENIUM SUPPLEMENT AND CLINICAL RESPONSES OF ACTIVE PULMONARY TUBERCULOSIS

  2006cited by this paper
• New Insights into the Evolutionary Links Relating to the 3-Deoxy-D-arabino-heptulosonate 7-Phosphate Synthase Subfamilies*

  2006cited by this paper
• Characterization of a recombinant type II 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Helicobacter pylori.

  2005cited by this paper
• DAHP synthase from Mycobacterium tuberculosis H37Rv: cloning, expression, and purification of functional enzyme.

  2005cited by this paper
• Expression, purification, and characterization of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase from Pyrococcus furiosus.

  2004cited by this paper
• (De)regulation of key enzyme steps in the shikimate pathway and phenylalanine-specific pathway of the actinomycete Amycolatopsis methanolica.

  2003cited by this paper
• Thermotoga maritima 3-Deoxy-D-arabino-heptulosonate 7-Phosphate (DAHP) Synthase

  2003cited by this paper
• Progress in TB drug development and what is still needed.

  2003cited by this paper
• In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production.

  2002cited by this paper
• In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E2 production

  2002cited by this paper
• The common aromatic amino acid biosynthesis pathway is essential in Mycobacterium tuberculosis.

  2002cited by this paper
• Microbial Origin of Plant-Type 2-Keto-3-Deoxy-d-arabino-Heptulosonate 7-Phosphate Synthases, Exemplified by the Chorismate- and Tryptophan-Regulated Enzyme from Xanthomonas campestris

  2001cited by this paper
• Serine 187 is a crucial residue for allosteric regulation of Corynebacterium glutamicum 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase.

  2001cited by this paper
• The power issue: determination of KB or Ki from IC50. A closer look at the Cheng-Prusoff equation, the Schild plot and related power equations.

  2001cited by this paper
• Interaction of the herbicide glyphosate with its target enzyme 5-enolpyruvylshikimate 3-phosphate synthase in atomic detail.

  2001cited by this paper
• Evaluation and Reparametrization of the OPLS-AA Force Field for Proteins via Comparison with Accurate Quantum Chemical Calculations on Peptides†

  2001cited by this paper
• Stigmatella aurantiaca Sg a15 carries genes encoding type I and type II 3-deoxy-d-arabino-heptulosonate-7-phosphate synthases: involvement of a type II synthase in aurachin biosynthesis

  2000cited by this paper
• UNDERSTANDING GLYPHOSATE'S MOLECULAR MODE OF ACTION WITH EPSP SYNTHASE : EVIDENCE FAVORING AN ALLOSTERIC INHIBITOR MODEL

  1997cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Evidence for a novel class of microbial 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase in Streptomyces coelicolor A3(2), Streptomyces rimosus and Neurospora crassa.

  1996cited by this paper
• Impaired Wound Induction of 3-Deoxy-D-arabino-heptulosonate-7-phosphate (DAHP) Synthase and Altered Stem Development in Transgenic Potato Plants Expressing a DAHP Synthase Antisense Construct

  1995cited by this paper
• The shikimate pathway--a metabolic tree with many branches.

  1990cited by this paper
• Purification and properties of the 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (phenylalanine-inhibitable) of Saccharomyces cerevisiae.

  1989cited by this paper
• 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase. Purification and molecular characterization of the phenylalanine-sensitive isoenzyme from Escherichia coli.

  1978cited by this paper
• Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes

  1977cited by this paper
• 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase. Purification, properties, and kinetics of the tyrosine-sensitive isoenzyme from Escherichia coli.

  1976cited by this paper
• Regulatory enzymes of aromatic amino acid biosynthesis in Bacillus subtilis. I. Purification and properties of 3-deoxy-D-arabino-heptulosonate 7-phosphate synthetase.

  1966cited by this paper
• Vascular Health and Risk Management Dovepress Olmesartan/amlodipine: a Review of Its Use in the Management of Hypertension

  year unknowncited by this paper

• Structural and biochemical analyses reveal Quinic acid inhibits DAHP Synthase a key player in Shikimate Pathway.

  2024cites this paper
• Multitargeting: An Alternative Approach to Tackling Multidrug Resistance Issues in Tuberculosis.

  2023cites this paper
• Natural products against key Mycobacterium tuberculosis enzymatic targets: Emerging opportunities for drug discovery.

  2021cites this paper
• Formulation and evaluation of β-cyclodextrin-mediated inclusion complexes of isoniazid scaffolds: molecular docking and in vitro assessment of antitubercular properties

  2020cites this paper
• Anti-tuberculosis activity of bio-active compounds from Lantana camara L., Euphorbia hirta L., Mukia maderaspatana (L.) M. Roem, and Abutilon indicum (L.)

  2020cites this paper
• Opportunities and challenges for flavonoids as potential leads for the treatment of tuberculosis

  2020cites this paper
• Mycobacterium tuberculosis Shikimate Pathway Enzymes as Targets for the Rational Design of Anti-Tuberculosis Drugs

  2020cites this paper
• Protein Dynamics and Inhibition of 3-Deoxy-arabino-heptulosonate-7-phosphate Synthase (DAHPS)

  2019cites this paper
• Non-antibiotic adjunctive therapy: A promising approach to fight tuberculosis.

  2019cites this paper
• Predictive Power of In Silico Approach to Evaluate Chemicals against M. tuberculosis: A Systematic Review

  2019influential citation
• Exploration of Mycobacterium tuberculosis structural proteome: An in-silico approach.

  2018cites this paper
• Development of machine learning models to predict inhibition of 3‐dehydroquinate dehydratase

  2018cites this paper
• Towards the Identification of Novel Phytochemical Leads as Macrodomain Inhibitors of Chikungunya Virus Using Molecular Docking Approach

  2017cites this paper
• วิศวกรรมเมแทบอลิคในวิถีชิคิเมตกับการสร้างสารเมแทบอไลต์ทุติยภูมิ (Metabolic engineering in the shikimate pathway and secondary metabolites production)

  2016cites this paper